The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 452.00
Bid: 444.00
Ask: 460.00
Change: -14.00 (-3.00%)
Spread: 16.00 (3.604%)
Open: 466.00
High: 466.00
Low: 445.00
Prev. Close: 466.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and Business Update

11 Oct 2021 07:00

RNS Number : 5466O
Science Group PLC
11 October 2021
 

 

 

 

11 October 2021

 

Science Group plc

 

Trading and Business Update

 

 

Following the business update on 6 September 2021, Science Group has continued to perform well. Despite component supply constraints, FX headwinds relative to prior year and increasing inflationary cost pressures, the Board anticipates further upside in the Group's 2021 profitability forecasts. This third upgrade during the current year reflects the strength of the Group, the success of the Frontier acquisition and the balance of financial discipline with investment for the future. It should also be noted that the advisor costs associated with the recent corporate activity have been expensed as incurred and are therefore absorbed within this profit upgrade.

 

Following the successful Placing in September, and after the strategic investment in TP Group plc, at 30 September 2021 Science Group had gross cash of £34.7 million and net funds of £19.1 million. Furthermore, the Board is currently discussing a potential new revolving credit facility of up to £25 million with the Group's bank, incremental to the existing fixed term loan which runs to 2026.

 

The Board continues to explore opportunities to deploy its capital, in conjunction with the Group's management resources, to enhance value to Science Group shareholders. These include both add-on acquisitions to accelerate the growth of the Group's existing operations and larger opportunities which would increase the scale of the Group.

 

Services Operations

 

The Group's services divisions have continued to perform well. The R&D Consultancy division continues to benefit from the global investment in the Medical sector but other industry sectors are now seeing increased activity in line with the economic recovery and Advisory services are experiencing the traditional increased activity as the year end approaches reflecting a progressive return to normality. The reorganisation of the division last year (integrating Advisory and Product Development services) has been well received by key clients and this has generated new service offerings. However, advanced-level technical and scientific resources remain in strong demand and recruitment is a priority.

 

The Regulatory & Compliance businesses are continuing to make steady progress, benefitting from recent investments, although TSG America has seen the anticipated slowing after the intensity of approval submissions related to the pandemic. The new IT finance system implemented in the TSG European business in 2020 has now also been successfully deployed into the Leatherhead Food Research business and a similar TSG America installation is progressing satisfactorily. When completed, all three operations in this division will be on the same core system. In parallel, the new rules-engine system designed to support the growth in the North American State registration renewals business has also now gone live and should assist in the intensive year end processing period.

 

Frontier Smart Technologies ("Frontier")

 

The Frontier acquisition in 2019 has been very successful, delivering substantial value to Science Group shareholders whilst enabling the Frontier business to realise its potential. Although demand continues to exceed supply, the global component shortages have been well managed by the Frontier team, despite lead times progressively extending, with some components now requiring orders for delivery into 2023. This is a tangible example of how Frontier has significantly benefitted from the acquisition and refinancing by Science Group, enabling a substantial improvement in supplier relationships which have been essential in maintaining component supplies during this challenging period. All cost increases have been passed on through the distribution channel.

 

Following the post-acquisition turnaround and integration, the Frontier strategy review initiated early in 2021 concluded that the business has a positive future, building on Frontier's market leading position in its defined markets and exploring new areas to enhance growth. These investments are now being made, with all costs being expensed. In addition, Frontier is in negotiations regarding an add-on acquisition to support its future strategy and, although there can be no certainty that the acquisition will complete, this potential investment reinforces the benefits that Frontier has gained as a division of Science Group.

 

Strategic Investment in TP Group plc ("TP Group")

 

Science Group initiated its investment in TP Group in August 2021 and now owns approximately 27% of the issued voting share capital, making Science Group the largest shareholder in TP Group. The total investment to date is approx. £12.5 million and the average cost per share is approx. 5.9 pence. Science Group recognises that additional capital investment may be required to ensure that TP Group has a solid financial foundation. The Science Group Board also anticipates that the market value of the shareholding will be impacted by the lack of liquidity resulting from the Group's stake, but considers the TP Group shareholding to be a long-term, strategic investment for Science Group.

 

Prior to, and during, the building of its stake, Science Group made a number of approaches to TP Group to try to discuss potential corporate collaboration models, including both a strategic investment and a possible offer for the company (at a significant premium) subject to satisfactory due diligence and other conditions. All these initiatives were rejected by TP Group without discussion or engagement and the possible Science Group offer was withdrawn on 3 September. Science Group therefore requisitioned a general meeting of TP Group shareholders which was held on 1 October 2021. As a result, two TP Group directors resigned and the appointments of two Science Group director nominees were approved by TP Group shareholders.

 

The onboarding process for the new directors is now underway and it is hoped that this will be completed shortly. It is anticipated that the future strategy of TP Group will be reviewed by the new Board once the Science Group director appointments are completed. Science Group believes that the strategic investment in TP Group offers an attractive opportunity for both organisations given the considerable similarities between the business operations but minimal overlap in client operating markets. Opportunities for collaboration and cooperation to benefit both organisations should be actively explored.

 

The Science Group representation on the TP Group Board should also improve financial management, increase focus on capital allocation and ensure greater alignment between stakeholders. The Science Group appointed directors will work with the TP Group management teams to ensure that the company has adequate capital resources and that such capital is invested in those business areas that can realise ambitious growth opportunities for TP Group and its employees, which in turn should ultimately produce an attractive return for shareholders in both TP Group and Science Group. 

 

Summary

 

Science Group's resilient operating performance has delivered a third upgrade to the Board's profitability expectations for the current financial year. This outstanding performance is due to the commitment and endeavours of the management and staff throughout the Group's operating businesses. These dedicated teams share in the Science Group success and can anticipate another year of excellent profit share and bonus awards.

 

In parallel, the Science Group strategy of enhancing the organic development of the Group's businesses through acquisitions and strategic investments continues to make progress. The Group's strategy will further benefit from the successful Placing in September, which expanded the institutional shareholder base, and the potential increase in credit facilities.

 

In summary, the Board anticipates that Science Group will close out 2021 as another outstanding year and is now starting to plan for 2022 and beyond.

 

 

 

End

 

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014). The person responsible for this announcement is Martyn Ratcliffe, Chairman.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVVIFLTIIL
Date   Source Headline
15th Jun 20217:00 amRNSTreasury shares issued and total voting rights
10th Jun 20217:00 amRNSTR1: Notification of Major Interest in Shares
7th Jun 20217:00 amRNSTreasury share issued and total voting rights
19th May 202111:15 amRNSResult of AGM
19th May 20217:00 amRNSTrading and Business Update
30th Apr 20215:00 pmRNSTotal Voting Rights
22nd Apr 202110:15 amRNSTR1: Notification of Major Interest in Shares
21st Apr 20215:00 pmRNSTR1: Notification of Major Interest in Shares
21st Apr 20217:00 amRNSTransaction in Own Shares
13th Apr 20217:00 amRNSTransaction in Own Shares
9th Apr 20217:00 amRNSPosting of AGM documents & Notice of AGM
22nd Mar 20217:00 amRNSIssue of share options and PDMR dealing
9th Mar 20217:00 amRNSAudited results for year ended 31 December 2020
4th Mar 20215:00 pmRNSTR1: Notification of Major Interest in Shares
11th Jan 20217:00 amRNSTrading, Business and Board Update
8th Jan 20214:40 pmRNSTR1: Notification of Major Interest in Shares
2nd Dec 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSTransaction in Own Shares
23rd Nov 20207:00 amRNSTransaction in Own Shares
20th Nov 20207:00 amRNSTransaction in Own Shares
18th Nov 20205:00 pmRNSTR1: Notification of Major Interest in Shares
16th Nov 202010:46 amRNSTransaction in Own Shares
16th Nov 202010:45 amRNSTransaction in Own Shares
16th Nov 20207:00 amRNSTransaction in Own Shares
13th Nov 20207:00 amRNSTransaction in Own Shares
11th Nov 20207:00 amRNSPDMR dealing
12th Oct 20207:00 amRNSTrading Update
8th Oct 20207:00 amRNSIssue of share options & PDMR dealing
5th Oct 20207:00 amRNSTR1: Notification of Major Interest in Shares
1st Oct 202011:15 amRNSTR1: Notification of Major Interest in Shares
30th Sep 20202:30 pmRNSDirector Dealing & Exercise of Share Options
30th Sep 20201:30 pmRNSProposed Director Dealing
10th Sep 20207:00 amRNSTrading and Dividend Update
28th Jul 20207:00 amRNSInterim Results for six month period ended 30/6/20
17th Jun 20207:01 amRNSBoard Appointment
17th Jun 20207:00 amRNSNominated Adviser and Joint Broker
16th Jun 202012:15 pmRNSResult of Annual General Meeting
16th Jun 20207:00 amRNSAGM Trading Update
9th Jun 20207:01 amRNSTR1: Notification of Major Interest in Shares
9th Jun 20207:00 amRNSTransaction in Own Shares
8th Jun 20207:00 amRNSTransaction in Own Shares
5th Jun 20207:00 amRNSTransaction in Own Shares
4th Jun 20207:00 amRNSTransaction in Own Shares
29th May 20207:00 amRNSTop Up of Bank Loan
22nd May 20207:00 amRNSTransaction in Own Shares
18th May 20207:00 amRNSTransaction in Own Shares
15th May 20207:00 amRNSPosting of AGM documents and Director Changes
11th May 20207:00 amRNSAGM Update, Capital Allocation and Dividend Policy
7th May 20204:50 pmRNSChange of auditors
7th May 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.